Management of multiple sclerosis in primary and secondary care
 
Status Complete
Anticipated publication date October 2014
Process CG
Topic area
  • Central nervous system

Email enquiries

Timeline

Key events during the development of the guidance

Date Update
29 April 2014

The draft guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.

3 August 2012

The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.

July 2012

The National Collaborating Centre (NCC) may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. The Health Economic plan, review questions and search strategies will be available on the website 5 weeks prior to consultation commencing.

8 May 2012

The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.

31 October 2011

The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.